Protokoly_diagnostiki_i_lechenia_zabolevany
.pdf" .
• 6 $ + ' % & & " ( 6 )?. 3 + ' & " &
& J!. |
|
• + # & |
&$ + ' , D ;. |
" , " , ( ), ?@. |
|
• + ' # "$ |
3 , 3 J! |
% & .
• 7 & + ' % & " 2 & [ .
•! / 2@ $ 3 + ' , %$ % D ;. G " " 3, &$ $ 3 J! & % &$.
•H "- % + '
/ 2 " & [ .
;/H ) ) +> )>' #A +G #">A9
• $ " $ ?.
• $ |
. |
• |
$ ? % & 10 |
( "[ ) ( . ).
•$ ? & && J!.
•! / $ $ & %[( ) " 3 & J!
?) + $: 15 ( " ) <) ! $: 15-30 ') ' $: 30 ( 0,5 / / ).
•! &$ $ "$ [ & (1000-1500 ) D (400800 ME), ( ) " ( , & ).
•+ " $ # & "-. J ?J•+?O ;> ? BO JM ;B B@?6B
J & $ ( V ! & ):
• B & " .
• & , "[ — .
• V ! $ & .
• ' ( " ) & 3 V ,% — " # 3 .
J! |
@ |
7 |
( ) |
|
|
|
|
* |
5 |
1 |
|
6 |
|
|
|
* |
4 |
5 |
|
; |
4 |
5 |
|
< * |
0,5 |
3.3 |
|
@ * |
0,5 |
3.3 |
|
• @ V &$ , . < (" 1~3 " ) ( 4~6 ) & , " , " .
-< * % ( ) () 3 (" 1-3 " ) ( 4-6 ) & ," , " .
-( , " , < ) & 1 ,( " ) — 0,5 , ( % ,$) — 0,25 .
-@ , " , &$ &$& " ! 1:1 0,9%% ( "$ &$ &1:2-1:5). ' J! .
- ! & & % & ; % & " # .
- + " " 24 " $" "
" 1 |
|
|
|
|
$, |
" |
|
|||||||
3 & " , |
J! . |
|
|
|
||||||||||
- ; , $# |
& |
, |
|
& |
|
|||||||||
3 ( 3 |
|
V |
||||||||||||
$# $). |
|
|
|
|
|
|
|
|
||||||
- V : |
|
|
|
|
|
|
||||||||
?) ( % & & 3 ) |
|
|
|
|
||||||||||
<) J$ % |
|
|
|
|
|
|
|
|
||||||
') + & & . |
|
|
|
|
|
|
|
|
|
|
||||
< |
& |
|
|
? |
|
& " |
||||||||
|
?, |
& |
& |
+ ' |
!, |
" & " |
|
|||||||
% & & % . "$: |
|
|
|
|
|
|
||||||||
- _. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-% " ! 7 |
|
|
|
|
|
|
|
|
|
|
|
|||
- % 20 |
|
|
|
|
|
|
|
|
|
|
|
|||
- . (9). |
|
|
|
|
|
|
|
|
|
|
|
|||
<ŸB> J D>+BO |
|
|
|
|
|
|
|
|
|
|
|
|
||
• " " |
& J! ( 3 |
|||||||||||||
|
|
?). |
|
|
||||||||||
• ? & J!. 3 "$ J! & "$ #[ (
). 7 & " |
& J! $ |
& , % & " 1,5~3 . |
|
• % " |
& |
-. @ " $ 3 &$ &$ " % # & "- # .
• ? — [ & (" " ) J! " 3 " .
( &
6?*.
@ : 7,5-25 1 $. 7 " " |
" . |
||
|
3 |
% & |
25 $. @ |
|
" |
? " & $ |
. & |
: +b, " , ?J; ACT 1 2 " 2 , — % .% % 6 ." " . '& .
J '.
@ : 3 100 / , — 20 / . 7 " 4—12 . & : % +b, ", ?J; ACT % " ,— 1 4—8 . 3 .
! &?*. 7 " 2 " . + " & — 5002 . L 1 "$ $ 1,5 , #[ " $ — 2 / . " 3 % & & % . & : % +b, ", ?J; ACT % 2 3 ,1 .
" & ( )C .
/ 1 $ $# : 10 , 20 , 501000 . ) "$ 50 % 2—4 . J $:" % V , # ( , 3 ) % & V , " (?J; ACT) % V .
" #
@ : * 5-6 / / , 3 / / . 7 % & " 2-3 & & " 1 6 . + &
&
9.*
@ : 3~5 / / 7 " " & " 1~3" 6 B. 6 : & ?@ % 2 " 2 , — % " .
G' ) " > G AG JG /9
@ J! ( & , *, *, *, *) # $ - 3 , " .
" & ( )B.
@ : 3 2 , 3 — " 9 / . J: " , +b, "% 2 " 3 " , — " % .
# C. *
@ : 1,5-2,5 / / . & : +b, " , ?J; ACT " % 2 " 2 , % .
$ $ C.* @ : 2-2,5 / / , % 3 — " 2-3 . & : % +b, ", ?J; ACT " % 2
" 2 , % . &. ' # & ".
< D. *
@ : 4-8 / . 7 " 2—3 . J : #& 1
$. + J! .
" C.*
@ : " & — 250-500 / ( 2 [ ), — " 750100 / . 7 " 3~6 .
<B J BL>! B> ? >+;™
! ! AT " + (-)B. ! : 3 / ( ) / . " 2 6 , — % 8 . < " 3 , . ! " & & , J!,& " &$. J. @ " & $" [ ( 6 , " [ ).
9 8 &, & & " . B+/B ™ '™< ? J!
• A*
• + ? ( " [& ) 3 B. ; , # . 3 " & " ? # .
• 3 " J! " % & " & .
' % % , 3 |
. |
• ' J! " & |
" |
?) ?: , , & , /
<) ?: & |
|
|
|
||||
') |
|
: |
|
, |
& , |
|
|
|
|
|
|
|
|
|
|
) ? |
( ): $ . |
||||||
• " |
" + ' , |
" 3 |
|||||
" |
3 |
$ |
& |
J! % |
|||
" & " $. |
|
|
|
||||
" & : |
|
|
|
||||
|
+ & |
|
|
|
|||
|
$ |
|
|
|
|
||
1. |
* 2 , V |
|
|
|
|||
2. |
*6 40 , |
V |
|||||
3.;
4.*< 0,1%, &,
5.*@ 0,5 , 1,5 , < &
6.*6 2,5 ,
7.J 10 , 20 , 100
8.*! & 500 , &
9.+ 10 , 20 , 50
10.200 ,
11.*G 250 ,
B 12. */ 25 , 100 ,
" & & :
1.& ?
2.*? 50 ,
3.*/ 50 , %
4.G 2 ,
5.* , 250 , ; 50 , 150 ,
6.*6 2,5 ,
!$$ |
! |
|
! % & |
||
/ |
, & : |
|
1. |
" $ " " . 6, 2004 . |
|
2. |
" |
$# " . 6, 2002 . |
3.Management of early rheumatoid arhtitis, National clinical guideline, Scottish Intergollegiate Guidelines Network, December 2000.
4.Clinical practice guideline for the management of rheumatoid arthritis. Spanish society of Rheumatology.2001.
5.+.+. & , ?.'.K “ M & : "“,D. + "- " ,81,2000 .
6.'.?. + ,+.'.< " . " ,6.,1997 .
7.>.'.K , .6. < , “! ' !: " ”, + "- " ,82, 2005 .
8.American College of Rheumatology Ad Hoc Commitee on Clinical Guidelines for the management of rheumatoid arthritis.Atrhtr. Rheum.,1996,39,713-722.
9.& " . - $# " . '.?.+ , >.J. + ,6 ,2003 .
* – , # (% % )
9 $
: 18-154
"$ &: " , & & -
:
& ! : " " " ; %
' & & : 28 &
(: ?51.5 ) : 9 $ - 3 , $#
" & &$, , $# # " ,% & .
9 $ - 3 & , $# " % , " , % & " &$ 2- .
$ :
1." .
2." .
3.' " % .
4.' " .
5.! , & &$ 2 .
6.! .
7.! .
8.; " .
9.! . ! ( ) "% & " &$ 2
% .
10. ! " . ! " % & "
% & |
% . ' 3 |
$"$ , " " |
. |
11.% . ' % ( 1 )( 2 ) .
12.% 2 .
13.! % .
14.! : - " 2 ; - " 2 .
15.! .
16.$# ".
17. ' & % .
* :
< " , " & & " " ( # , % , & . .)," & , , " & # % # .
: |
& " , |
" , & " . |
|
" : |
|
" |
: |
1. ! &- $; , /(! ? ) 8695 2001 . «
& , ») % & " .
2. J , $# % & " .
5 :
1.# ;
2.# " ;
3.;
4._ $;
5.' ;
6. B 'BL ( 89 |
6) 18 1999 . 575 6) |
|
11 $ |
2002 . « % |
& 'BL- |
$»- |
% &$ 'BL- $ & |
|
, , . & ). |
||
|
: |
|
1.@ : 2 & , ., " 3-3 , , , " ; &: " " 3- , , ".
2.% & " ( ' ,$, ,
, |
$) |
" |
. |
||
3. |
|
-O ( ) |
|
" |
|
|
. |
|
|
|
|
4. |
& |
" |
|
||
" |
" " . |
|
|
||
" & :
1.#
2.# "
3.B 'BL
4.B_?-+'sAg
5.B (B_?)
6.$
7./
8.!
" & & |
|
: |
||
1. |
& |
|
||
2. |
& & |
|
|
|
3. |
& |
|
|
|
4.B $, %%
5.B_?
6.B
+ :
7 :
6 1: J " G 2,4 . >@ V$, 1 $, 83; -1 2,4 . >@ V$, 1 5 , 86.
6 2: J " # -3, 1,8 >@ 2$- 810; -5 1500000 >@, 2 $- 810.
6 3: |
- 1,2 , % |
||
- 820, & |
600000 >@ 2 - 20 . |
||
6 4: ; # |
1 . >@ " |
||
6 " 4 " 20 . |
|
||
6 5 ( |
& |
" & , |
|
, ): |
|
||
|
0,1 " 8 " 3 " 30 , |
||
9 ; 0,5 " 6 " 4 " 30 , 60 . 7 0,5 4 , " 30 , " 6 " , 60 . ? 0,5 " 12 " 2 , " 3- &.
6 6: / 1,0 % 4 " 6 , " 28 .
6 7: / 1,0 1 & " & " , 10,0 .
@ " "$ $ $& 200 2 \ " 21 150 13 - 2-3 .
" & :
1.< . / 1000000 >@,
2./ 1 ,
3.? 1 ,
4.< G 2,4 >@,
5.< &600000 >@,
" & & :
4.@ 100 ,
1.7 500 ,
2.? 500 ,
3.; 100 , 200 ,
4.B & 150 – 10 \
5._ 150 ,
6./ 1 ,
7. ' ', !
8.B : 500 , .
9.< : 3, .
|
,- ! : |
" " . |
< & , |
" " |
" , % -" |
$ " 3- " &$ " $ ' 1 3 .
/ , & :
1.Syphilis National Guideline Clearighouse www. guideline.gov.
2.2002 national guidelines on the management of early syphilis. National Guideline Clearighouse www. guideline.gov.
3.% " . " . ' .M. .! , '.+. 6 .- 6., 6 , 1999.
4.J " ( " ). + "- & %-" . ? , 2004 .
* – , # (% % )
9$ $ –
: 19-165
"$ &: "
:
& ! : " " & "
' & & :
30-40 - .
' % & " &– :
" ( . 12 “ " ”, ) 16.04.1997 . 8 96-1) – $ 3 " .
(:
F 45 ! F45.0 !
F45.1 +
F45.2 B "
F45.3 !
F45.4 G "
F45.8: @
F45.9 ! , "
) : 9$ – , #& " % " $# ( " %$" & ).$# "%$# & &" " . > "$, V$ % &" & .
$ : 6 <-10
* :
! ; ' " ( .);
6 & ( . .); " % &;
+ " ( , % - );
& &-3 " |
|
( & |
|
% |
3 , % |
" % .) |
|||
" : |
|
|
|
|
" |
: |
|
|
|
1.' % & / % & "" V .
2.J ,
" , 3 , 3 . 3. + & .
5
1.+ ' +@ ( ) , $#" , " $# $" "-.
2._ $ ( );
3.6 ( & RW).
|
: |
@ |
F 45. % & " |
, V " .
@ F 45.0: + " % % & "" 2- .
@ F 45.1: ! " % % , & & , %" " % F 45.2 + " # % " , $# 6 " &
% |
" , |
|
" |
|
|
@ F 45.3: ! % , & # |
||
, " & " |
&& |
|
, $ V
@ F 45.4: @ # 6 % " $# &,– " " , 3 & V &, ,
@ F 45.8: D & "$ & "
" & :
1.# (6 );
2.# " ;
3.?J;, ?!;;
4.;
5.7 ;
6.& : ;
7.& : ;
8.7 & – " ( " ).
" & & :
1. 7 & – " ( );
2.3 ;
3.H & ;
4. |
B . ; |
5. |
B / . |
+ |
: |
:
1. " , $ "" , . ' ":
-;
-$;
-V V ;
2.# " " .
3.7 & – " .
4., & $ & , & ,